Biological brain age prediction using machine learning on structural neuroimaging data: multi-cohort validation against biomarkers of Alzheimer's disease and neurodegeneration stratified by sex
Abstract
Brain-age can be inferred from structural neuroimaging and compared to chronological age (brain-age delta) as a marker of biological brain aging. Accelerated aging has been found in neurodegenerative disorders like Alzheimer's disease (AD), but its validation against markers of neurodegeneration and AD is lacking. Here, imaging-derived measures from the UK Biobank dataset (N=22,661) were used to predict brain-age in 2,314 cognitively unimpaired (CU) individuals at higher risk of AD and mild cognitive impaired (MCI) patients from four independent cohorts with available biomarker data: ALFA+, ADNI, EPAD and OASIS. Brain-age delta was associated with abnormal amyloid-b, more advanced stages (AT) of AD pathology and APOE-e4 status. Brain-age delta was positively associated with plasma neurofilament light, a marker of neurodegeneration, and sex differences in the brain effects of this marker were found. These results validate brain-age delta as a non-invasive marker of biological brain aging in non-demented individuals with abnormal levels of biomarkers of AD and axonal injury.
Data availability
UKBiobank data availability at www.ukbiobank.ac.ukADNI data availability at https://adni.loni.usc.edu/EPAD data availability at www.ep-ad.org/ALFA: data availability through GAAIN at https://www.gaaindata.org/partners/online.htmlFully steps and instructions on data access can be found in the following links:UKBiobank: https://www.ukbiobank.ac.uk/enable-your-research/apply-for-accessADNI: https://adni.loni.usc.edu/data-samples/access-data/EPAD: https://ep-ad.org/open-access-data/access/ALFA: https://www.gaaindata.org/partner/ALFA
Article and author information
Author details
Funding
European Union's Horizon 2020 Research and Innovation (948677)
- Marc Suárez-Calvet
Instituto de Salud Carlos III (PI19/00155)
- Marc Suárez-Calvet
La Caixa Foundation (100010434)
- Marc Suárez-Calvet
European Union's Horizon 2020 Research and Innovation (847648)
- Marc Suárez-Calvet
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: ALFA ethics: All participants were enrolled in the ALFA (ALzheimer and FAmilies) study (Clinicaltrials.gov Identifier: NCT01835717. The study was approved by the Independent Ethics Committee "Parc de Salut Mar," Barcelona, and all participants gave written informed consent.
Copyright
© 2023, Cumplido-Mayoral et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,517
- views
-
- 530
- downloads
-
- 35
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.